One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Access
Search from 250 M+ research papersSearch from 250 M+ research papers
Open Accesshttps://doi.org/10.1182/blood-2018-99-114648
Copy DOI Journal: Blood |  Publication Date: Nov 29, 2018 |
Affiliation: University Hospital Ulm, Hannover Medical School, University Medical Center Hamburg-Eppendorf, Universität Hamburg, University Cancer Center Hamburg, Düsseldorf University Hospital, Heinrich Heine University Düsseldorf, University Hospital Bonn, Kliniken Essen-Mitte, Klinikum Braunschweig, Katharinenhospital, German Cancer Research Center, Heidelberg University, Städtisches Klinikum Karlsruhe, University Medical Center Freiburg, Johannes Gutenberg University Mainz, University Medical Center of the Johannes Gutenberg University Mainz, University of Lübeck, University Hospital Schleswig-Holstein, Universitätsmedizin Göttingen, Rechts der Isar Hospital, National Center for Tumor DiseasesAssessment of Treatment Effects By Measurable Residual Disease Monitoring in NPM1-Mutated AML Patients Randomized for Gemtuzumab-Ozogamicin (GO) within the AMLSG 09-09 Trial of the German-Austrian AML Study Group (AMLSG)
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
